BRCA2 mutations, often linked to DNA repair defects, may influence tumor progression, while GPC3, involved in cell signaling and adhesion, may play a role in HB biology, although its precise contribution requires further validation [23]. The gene discussed is BRCA2; the disease is hemoglobin measurement.